The Intelligent Cath Lab: GE HealthCare, Laza Medical and the Road From AI Imaging to Robotic Intervention
Dr. Dereck Mush, MD, MBA
Evident Vascular
AI-powered intravascular ultrasound platform for peripheral imaging.
What they do
Evident Vascular announced on November 4, 2026 FDA 510(k) clearance (K261648, decision dated October 28, 2026) of the Evident Vascular Guidance System and peripheral imaging catheters. The platform offers flushless plug-and-play peripheral catheters, voice control and real-time processing on NVIDIA accelerated computing. It is not yet available for sale; clearance is not approval.
The record
- Vertical
- Cardiovascular
- Sub-segment
- AI-powered intravascular ultrasound
- Product type
- Medical device
- Stage
- Venture-backed
- Headquarters
- San Jose, California, United States
- Region
- North America
- Founded
- Not disclosed
- Total funding
- Undisclosed
Also in Cardiovascular
Related on The Signal
Dr. Dereck Mush, MD, MBA
Planning Moves Upstream: What the P4 Trial Means for CT, IVUS and the Economics of the Cath Lab
Dr. Dereck Mush, MD, MBA
Cyclical Mechanics vs. Static Vacuum: The Next Battleground in Endovascular Thrombectomy
Dr. Dereck Mush, MD, MBA
Inside RIVANNA's BoneEnhance: Making Volumetric Ultrasound Easier to Read
Dr. Dereck Mush, MD, MBA